InvestorsHub Logo
Followers 16
Posts 1545
Boards Moderated 0
Alias Born 12/13/2009

Re: skitahoe post# 457033

Thursday, 04/18/2024 8:27:01 PM

Thursday, April 18, 2024 8:27:01 PM

Post# of 462467

the way I'd show what I had is by applying for approval to the regulators. I believe that even in RETT's they have sufficient data to take a shot



My opinion is that AVXL will certainly not proceed with an NDA for Rett approval based on a technical trial failure to meet endpoints without the FDA's encouragement. By the way, has AVXL even requested a meeting with regulators to discuss the EXCELLENCE results? Nearly four months have passed since the top line data was released. Will we see full data by mid-year 2024? It could easily be late 2024, or later, before shareholders see any additional clarity about any path forward in Rett Syndrome.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News